Situation

As North America’s leading testing, certification and repair platform, MTA has built a strong reputation for exceptional service. The Company has experienced over 20 years of organic growth, supplemented by a clearly defined acquisition strategy, supported in partnership by its financial sponsor, Riverarch. The MTA team engaged G2 Capital Advisors, LLC (“G2”) with a focus on identifying and driving growth through targeted geographic expansion and service-line extensions to offer additional services to the Company’s existing client base and foster new customer relationships. 

Engagement

G2 served as the exclusive buy-side advisor to MTA, leading a search targeted at identifying and engaging with companies with an established market position and strong reputation for quality service. 

Outcome

G2’s mandate with MTA led to the successful acquisition of Florida-based Stat Biomedical, LLC (“Stat Biomedical”), further enhancing MTA’s position as a leading provider of biomedical equipment calibration and repair services. Stat Biomedical delivers a full suite of solutions, including safety inspections, equipment calibration, preventative maintenance, and repair services, supporting medical offices, clinics, and surgical centers in maintaining high-performing equipment and meeting OSHA compliance standards. By adding Stat Biomedical’s capabilities, MTA broadens its technical expertise and reinforces its role as a comprehensive, single-source partner for healthcare providers nationwide. The acquisition strengthens MTA’s platform for continued expansion and deepens its ability to deliver consistent, high-quality service and value to customers across the United States.

“Integrating Stat Biomedical into the MTA platform meaningfully expands our expertise in biomedical equipment repair and calibration,” said Dusty Abbs, COO of MTA. “Their reputation for skilled, responsive service has built an impressive business, and we look forward to the enhanced value this partnership will bring to our customers.”

“This represents the third acquisition we’ve had the privilege to support for MTA, reinforcing G2’s commitment to helping strong, market-leading companies scale through disciplined inorganic growth,” said Dan Almon, Director at G2. “We are proud to play a role in MTA’s continued expansion and look forward to deepening our partnership with the Riverarch team as the platform advances its capabilities.”